Literature DB >> 18472328

Exon copy number alterations of the CHD7 gene are not a major cause of CHARGE and CHARGE-like syndrome.

Jorieke E H Bergman1, Ilse de Wijs, Marjolijn C J Jongmans, Ronald J Admiraal, Lies H Hoefsloot, Conny M A van Ravenswaaij-Arts.   

Abstract

CHARGE syndrome is a multiple congenital anomaly syndrome caused by mutations in the CHD7 gene. Mutations in this gene are found in 60-70% of patients suspected of having CHARGE syndrome. However, if only typical CHARGE patients are taken into account, mutations in the CHD7 gene are found in over 90% of cases. The remaining 10% might be caused by hitherto undetected alterations of the CHD7 gene, including whole exon duplications and deletions that are missed by the currently used diagnostic procedures. Therefore we looked for these kinds of alterations by multiplex ligation-dependent probe amplification in 54 patients suspected of having CHARGE syndrome without a CHD7 mutation. In one patient a partial deletion of the CHD7 gene (exons 13-38) was identified, while in the other patients no abnormalities were found. The frequency of exon deletions in our cohort was 1.9% (1/54) and 5.6% (1/18) in all patients and in typical CHARGE patients, respectively. We conclude that exon copy number alterations of the CHD7 gene are not a major cause of CHARGE and CHARGE-like syndrome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18472328     DOI: 10.1016/j.ejmg.2008.03.003

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  13 in total

Review 1.  Chromodomain proteins in development: lessons from CHARGE syndrome.

Authors:  W S Layman; E A Hurd; D M Martin
Journal:  Clin Genet       Date:  2010-04-08       Impact factor: 4.438

2.  Prevalence of genetic testing in CHARGE syndrome.

Authors:  Timothy S Hartshorne; Kasee K Stratton; Conny M A van Ravenswaaij-Arts
Journal:  J Genet Couns       Date:  2010-09-28       Impact factor: 2.537

3.  Clinical utility gene card for: CHARGE syndrome.

Authors:  Kim Blake; Conny M A van Ravenswaaij-Arts; Lies Hoefsloot; Alain Verloes
Journal:  Eur J Hum Genet       Date:  2011-03-16       Impact factor: 4.246

4.  Clinical utility gene card for: CHARGE syndrome - update 2015.

Authors:  Conny M A van Ravenswaaij-Arts; Kim Blake; Lies Hoefsloot; Alain Verloes
Journal:  Eur J Hum Genet       Date:  2015-02-18       Impact factor: 4.246

5.  More Clinical Overlap between 22q11.2 Deletion Syndrome and CHARGE Syndrome than Often Anticipated.

Authors:  N Corsten-Janssen; S C Saitta; L H Hoefsloot; D M McDonald-McGinn; D A Driscoll; R Derks; K A Dickinson; W S Kerstjens-Frederikse; B S Emanuel; E H Zackai; C M A van Ravenswaaij-Arts
Journal:  Mol Syndromol       Date:  2013-05-28

Review 6.  Molecular and phenotypic aspects of CHD7 mutation in CHARGE syndrome.

Authors:  Gabriel E Zentner; Wanda S Layman; Donna M Martin; Peter C Scacheri
Journal:  Am J Med Genet A       Date:  2010-03       Impact factor: 2.802

7.  Mutations in the CHD7 gene: the experience of a commercial laboratory.

Authors:  Cynthia F Bartels; Cheryl Scacheri; Lashonda White; Peter C Scacheri; Sherri Bale
Journal:  Genet Test Mol Biomarkers       Date:  2010-12

8.  Prevalence and Phenotypic Effects of Copy Number Variants in Isolated Hypogonadotropic Hypogonadism.

Authors:  Maria I Stamou; Harrison Brand; Mei Wang; Isaac Wong; Margaret F Lippincott; Lacey Plummer; William F Crowley; Michael Talkowski; Stephanie Seminara; Ravikumar Balasubramanian
Journal:  J Clin Endocrinol Metab       Date:  2022-07-14       Impact factor: 6.134

9.  Cerebellar vermis hypoplasia in CHARGE syndrome: clinical and molecular characterization of 18 unrelated Korean patients.

Authors:  Young Bae Sohn; Jung Min Ko; Choong Ho Shin; Sei Won Yang; Jong-Hee Chae; Kyung-A Lee
Journal:  J Hum Genet       Date:  2015-11-05       Impact factor: 3.172

10.  CHD7 mutations in patients initially diagnosed with Kallmann syndrome--the clinical overlap with CHARGE syndrome.

Authors:  M C J Jongmans; C M A van Ravenswaaij-Arts; N Pitteloud; T Ogata; N Sato; H L Claahsen-van der Grinten; K van der Donk; S Seminara; J E H Bergman; H G Brunner; W F Crowley; L H Hoefsloot
Journal:  Clin Genet       Date:  2008-11-17       Impact factor: 4.438

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.